Registration number:
Heart Health Ltd
for the Year Ended 28 February 2022
Heart Health Ltd
Contents
Company Information |
|
Balance Sheet |
|
Notes to the Unaudited Financial Statements |
Heart Health Ltd
Company Information
Directors |
P Ramrakha S Ramrakha |
Registered office |
|
Accountants |
|
Heart Health Ltd
(Registration number: 11204592)
Balance Sheet as at 28 February 2022
Note |
2022 |
2021 |
|
Fixed assets |
|||
Intangible assets |
|
|
|
Tangible assets |
- |
|
|
|
|
||
Current assets |
|||
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net current liabilities |
( |
( |
|
Net liabilities |
( |
( |
|
Capital and reserves |
|||
Called up share capital |
2 |
2 |
|
Retained earnings |
(108,141) |
(88,656) |
|
Shareholders' deficit |
(108,139) |
(88,654) |
Heart Health Ltd
(Registration number: 11204592)
Balance Sheet as at 28 February 2022
For the financial year ending 28 February 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
......................................... |
Heart Health Ltd
Notes to the Unaudited Financial Statements for the Year Ended 28 February 2022
General information |
The company is a private company limited by share capital, incorporated in England.
The address of its registered office is:
United Kingdom
These financial statements were authorised for issue by the
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Going concern
At 28 February 2022 the company's balance sheet showed a deficit on shareholders' funds of £108,139. The company relies on the support of its director's and related companies. The directors consider that this support will continue for a period of twelve months from the date of the approval of these accounts. The directors therefore believe that it is appropriate to prepare these accounts on a going concern basis and no adjustments have been made which would be require if that basis were to be inappropriate.
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
- the amount of revenue can be reliably measured;
- it is probable that future economic benefits will flow to the entity; and
- specific criteria have been met for each of the company's activities.
Heart Health Ltd
Notes to the Unaudited Financial Statements for the Year Ended 28 February 2022
Tangible assets
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
Asset class |
Depreciation method and rate |
Office equipment |
Straight line @ 33% |
Amortisation
Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:
Asset class |
Amortisation method and rate |
Application Software |
Straight line over 10 years |
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
Heart Health Ltd
Notes to the Unaudited Financial Statements for the Year Ended 28 February 2022
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
Heart Health Ltd
Notes to the Unaudited Financial Statements for the Year Ended 28 February 2022
Loss before tax |
Arrived at after charging/(crediting)
2022 |
2021 |
|
Depreciation expense |
|
|
Amortisation expense |
|
|
Intangible assets |
Other intangible assets |
Total |
|
Cost or valuation |
||
At 1 March 2021 |
|
|
At 28 February 2022 |
|
|
Amortisation |
||
At 1 March 2021 |
|
|
Amortisation charge |
|
|
At 28 February 2022 |
|
|
Carrying amount |
||
At 28 February 2022 |
|
|
At 28 February 2021 |
|
|
Heart Health Ltd
Notes to the Unaudited Financial Statements for the Year Ended 28 February 2022
Tangible assets |
Furniture, fittings and equipment |
Total |
|
Cost or valuation |
||
At 1 March 2021 |
|
|
At 28 February 2022 |
|
|
Depreciation |
||
At 1 March 2021 |
|
|
Charge for the year |
|
|
At 28 February 2022 |
|
|
Carrying amount |
||
At 28 February 2022 |
- |
- |
At 28 February 2021 |
|
|
Debtors |
Current |
2022 |
2021 |
Trade debtors |
- |
|
Other debtors |
|
|
|
|
Heart Health Ltd
Notes to the Unaudited Financial Statements for the Year Ended 28 February 2022
Creditors |
Creditors: amounts falling due within one year
2022 |
2021 |
|
Due within one year |
||
Other creditors |
|
|
Share capital |
Allotted, called up and fully paid shares
2022 |
2021 |
|||
No. |
£ |
No. |
£ |
|
|
|
2 |
|
2 |
Related party transactions |
Summary of transactions with entities with joint control or significant interest
(A company controlled by one of the directors)
The Chiltern Hills Heart Clinic Limited
(A company controlled by one of the directors)
Expenditure with and payables to related parties
2022 |
Entities with joint control or significant influence |
Amounts payable to related party |
|
|
2021 |
Entities with joint control or significant influence |
Amounts payable to related party |
|
|